Clínic Barcelona

Immunotherapy proves to be effective for the treatment of chronic rhinosinusitis with nasal polyps

An international study shows the efficacy of a monoclonal antibody, Dupilumab, to treat chronic rhinosinusitis with nasal polyposis, when the standard treatment with intranasal corticosteroids does not work. The Journal of the American Medical Association (JAMA) publishes the results. Dr. Joaquim Mullol, director of the Rhinology Unit and Smell Clinic at the Otorhinolaryngology Department of Hospital Clinic and coordinator of the Clinical and Experimental Respiratory Immunoallergy IDIBAPS research team, has participated in this preliminary phase II study.